Two-Day pill trial aims to fight frailty in kidney patients
NCT ID NCT03325322
Summary
This study is testing whether a short, two-day course of a compound called fisetin can help people with advanced chronic kidney disease. Researchers want to see if fisetin can reduce body-wide inflammation, improve the function of certain repair cells, and help with physical strength and kidney function. About 30 participants will take either fisetin or a placebo and be followed for a year to check for effects and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.